Drugs / carb
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT07380633 Comparator | Jan 2026 → Dec 2027 expected | hepatocellular carcinoma | Sun Yat-sen University | Active not recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | carb | “using 30 mg/m2 of epirubicin, 300mg/m2 carb mixed with 2-5 mL lipiodol” NCT07380633 ↗ |